Submission Details
| 510(k) Number | K930421 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 26, 1993 |
| Decision Date | March 10, 1993 |
| Days to Decision | 43 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
K930421 is an FDA 510(k) clearance for the ELIAS DSDNA ABS, a System, Test, Systemic Lupus Erythematosus (Class II — Special Controls, product code DHC), submitted by Elias U.S.A., Inc. (Osceola, US). The FDA issued a Cleared decision on March 10, 1993, 43 days after receiving the submission on January 26, 1993. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5820.
| 510(k) Number | K930421 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 26, 1993 |
| Decision Date | March 10, 1993 |
| Days to Decision | 43 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
| Product Code | DHC — System, Test, Systemic Lupus Erythematosus |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5820 |